Companies/US/KMTS

KESTRA MEDICAL TECHNOLOGIES, LTD.

Income flow

Annual
KMTS 10-K Income StatementPeriod 2026-04-30Source 10-K
Net sales$95M+59% Y/YRevenue$95M+59% Y/YGross profit$49M+102% Y/YCost of revenue$46M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0Shares outTotal shares currently outstanding (issued and not retired).59.6MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).33.7M